TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹156 Cr | ₹157 Cr | ₹151 Cr | ₹129 Cr | ₹123 Cr |
What is the latest Contingent Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹156 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹151 Cr |
| Mar2022 | ₹129 Cr |
| Mar2021 | ₹123 Cr |
How is Contingent Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹156 Cr | -0.84 | |
| Mar2024 | ₹157 Cr | 4.38 | |
| Mar2023 | ₹151 Cr | 17.16 | |
| Mar2022 | ₹129 Cr | 4.76 | |
| Mar2021 | ₹123 Cr | - | |
Compare Contingent Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹140,640.7 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
| MANKIND PHARMA | ₹87,624.9 Cr | 3.9% | -5.4% | -12.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3.2% |
-6.2% |
29.3% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses